About this Medicine article
Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study by Richards, D. A. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Richards, D. A.
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2006
- Language
- EN
- Field
- Medicine (Health Sciences)